TP53 and cancer: fabricated DSPE-PEG-AA(1,2-distearoryl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol-2000)] ammonium salt-anisamide) modified high-density lipoprotein-based nanoparticles (DSPE-PEG-AA/rHDL) for co-encapsulation of dichloroacetate (DCA) and p53 together for potential cancer treatment (Zhang et al., 2016a).